None listed
Conditions
Interventions
Intervention1: Misoprostol: Dose 50 microgram
Frequency-every 4 hourly
route-ORAL
Control Intervention1: Vaginal Misoprostol, oral misoprostol: Misoprostol 25mcg intravaginal vs
Misoprostol 50mcg oral
Sponsors
Sikkim Manipal Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria were nulliparous and multiparous women with singleton pregnancy between 37 to 42 weeks, with obstetric or medical indications for induction, and unfavorable cervix (the initial Bishop score of <=6), vertex presentation, reactive fetal heart rate pattern, absence of labor/uterine contractions.
Exclusion criteria
Exclusion criteria: Women who were excluded from the study were malpresentations, presence of labor/uterine contractions, Suspected cephaloâ??pelvic disproportion, estimated fetal weight of >4000 grams, maternal age of =5, favorable cervix (Bishop Score >6), previous caesarean delivery or history of uterine scar, multiple gestations, undiagnosed vaginal bleeding, fetal distress, any contraindication for vaginal delivery or prostaglandins administration and suspected chorioamnionitis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes that were studied to judge the efficacy of two routes of misoprostol were the induction to delivery interval in those delivering vaginally and vaginal delivery rate within 24 hoursTimepoint: 24 HOUR | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome measures used to evaluate the efficacy or safety included the number of doses of misoprostol needed to induce delivery, oxytocin requirement, the incidence of failed inductions, the rate of cesarean sections, maternal adverse effectsTimepoint: 24 hour | — |
Countries
India
Contacts
Public ContactDr Hafizur Rahman
Outcome results
None listed